Partnerships
We discover functionally active antibody drugs for our partners’ challenging targets
Using our platform and proprietary antibody libraries, we’ve discovered activating antibodies for multiple GPCRs. Let us create activators and modulators for your targets.
We’re dedicated to expanding the impact of activating and modulating antibody therapeuitcs to as many targets and diseases as possible through key partnerships.
Partnering with Abalone Bio
Discovery partnerships
Abalone Bio’s unique high-throughput platform creates antibodies that modulate target activity. While our internal pipeline is currently focused on agonists and positive modulators, we can also find negative modulators and inhibitors for your targets.
Asset co-development partnerships
We are developing antibody agonists against multiple targets spanning multiple indications including metabolic disease (including obesity), inflammation, and cancer. We are excited to develop these much-needed therapeutics with the right development and commercialization partners.
